Your session is about to expire
← Back to Search
Mobile Health Interventions for Cardiovascular Health (MHC Trial)
N/A
Recruiting
Led By Euan Ashley, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 weeks
Awards & highlights
MHC Trial Summary
This trial will use the mobile health capabilities of smartphones and wearables to assess daily activity measures of the general population and compare these to measures of cardiovascular health risk factors and fitness.
Who is the study for?
This trial is for adults over the age of 18 who are interested in contributing to research on cardiovascular health. It aims to gather data using smartphones and wearables to track daily activities like exercise, sedentary behavior, and sleep.Check my eligibility
What is being tested?
The study tests four types of prompts (Stand Prompt, Step Prompt, Cluster Prompt, Read AHA website) designed to increase physical activity. Participants' step counts will be monitored to measure the effectiveness of these prompts.See study design
What are the potential side effects?
Since this study involves non-invasive tracking of activity through mobile devices and does not include medication or medical procedures, no direct side effects are expected from participating.
MHC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Activity frequency and duration as Measured By Smartphone Core Motion Chip Sensor (Step count as seen in Apple's Healthkit)
Secondary outcome measures
Cardiovascular Diseases
Change in self reported levels of happiness as indicated on a numerical gradient scale and self reported by participant using the OECD Guidelines on Measuring Subjective Well Being survey
Change in self reported sleep duration obtained from a daily user survey.
+1 moreMHC Trial Design
5Treatment groups
Active Control
Placebo Group
Group I: Cluster PromptActive Control1 Intervention
The participant will receive daily information notifications specific to the activity cluster they fall into based on the activity data collected in phase 1 of the study.
Group II: Baseline monitoringActive Control1 Intervention
No feedback is provided to the users. This is the control arm.
Group III: Stand PromptActive Control1 Intervention
Behavioral Intervention Prompt- Participant will receive a notification asking them to stand and walk if they have been sitting for longer than 60 minutes.
Group IV: Step PromptActive Control1 Intervention
The participant will receive a notification if they are below 5000 steps by 3pm each day asking them to get to 10000 steps.
Group V: Read AHA websitePlacebo Group1 Intervention
Daily reminder to read the American Heart Association (AHA) website.
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,408 Previous Clinical Trials
15,343,248 Total Patients Enrolled
1 Trials studying Cardiovascular Health
Euan Ashley, MDPrincipal Investigator - Stanford University
Stanford Hospital, Stanford Hospital and Clinic
University Of Glasgow (Medical School)
Stanford University Hospital (Residency)
1 Previous Clinical Trials
24 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am under 18 years old.I am over 18 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Cluster Prompt
- Group 2: Baseline monitoring
- Group 3: Stand Prompt
- Group 4: Step Prompt
- Group 5: Read AHA website
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger